Moderna announced Friday that it has requested emergency use authorization for its omicron COVID-19 booster shots for children aged 6-17 years old.
Driving the news: The application for the bivalent vaccine for children ages 6 months to under 6 years old is expected to be completed later this year, the company said on Twitter.